This site is intended for healthcare professionals only
LoginRegister
Abacavir, Dolutegravir and Lamivudine Tablets for Oral SuspensionLupin gets USFDA tentative nod for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension...
Cipla Global CMO Rajeev Kumar Sinha resignsCipla Global Chief Manufacturing Officer Rajeev Kumar Sinha resigns
Granules recalls over 33000 bottles BP medication in USZydus Lifesciences Dapsone Gel Recalled by USFDA
NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; DetailsNPPA Directs Drug Makers to Submit Data for Ceiling Prices of Lohexol, IV Fluids
Ajanta Pharma confirms IT Department searchIT Dept searches offices, manufacturing facilities of Akums Drugs, its subsidiaries
USFDA concludes audit at Cohance Lifesciences Jaggaiahpet facilityLaurus Labs US arm gets 1 USFDA observation
Insufficient Efficacy, Safety Data: CDSCO Panel Rejects Zydus Phase III CT Waiver Request for VoclosporinZydus Usnoflast gets USFDA Orphan Drug Designation for amyotrophic lateral sclerosis
Child Given Wrong Injection at Government HospitalPiramal Critical Care launches Chlorpromazine Hydrochloride for Injection in US
Emcure Pharma inaugurates RnD centre in GujaratEmcure Pharma inaugurates RnD centre in Gujarat
Last Chance: PCI Extends Deadline for 2025-26 Academic Year ApprovalsLast Chance: PCI Extends Deadline for 2025-26 Academic Year Approvals
Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapySanofi Healthcare India gets CDSCO Panel nod to study Nirsevimab
AstraZeneca Gets SEC Approval to Conduct Phase IV Trial of Hyperkalemia Drug Sodium Zirconium CyclosilicateCDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal for Anti-cancer Drug Volrustomig...
X